Windtree Therapeutics
WINT • NASDAQ
Windtree Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jed A. Latkin.
CEOJed A. Latkin
Next Earnings
No upcoming earnings scheduled for Windtree Therapeutics
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for Windtree Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2025 | Q3 2025 | -$1.08 | — | - | — |  10-Q |
| Aug 19, 2025 | Q2 2025 | -$3.06 | — | - | — | 10-Q |
| May 16, 2025 | Q4 2024 | -$4.63 | — | - | — | — |
| Nov 27, 2024 | Q3 2024 | -$211.50 | — | - | — | 10-Q |
| Aug 19, 2024 | Q2 2024 | -$1,045.50 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$462.00 | — | - | — | 10-Q |
| Apr 17, 2024 | Q4 2023 | -$855.00Est: -$846.00 | -1.1% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$774.00Est: -$567.00 | -36.5% | - | — | — |
| Aug 7, 2023 | Q2 2023 | -$1,476.00Est: -$612.00 | -141.2% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$4,284.00Est: -$504.00 | -750.0% | - | — | 10-Q |
| Apr 3, 2023 | Q4 2022 | -$11,709.00 | — | -Est: $100.0K | -100.0% | — |
| Nov 14, 2022 | Q3 2022 | -$5,850.00Est: -$11,700.00 | +50.0% | - | — | — |